These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 4309925

  • 21. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
    Bull World Health Organ; 1969; 40(6):925-45. PubMed ID: 4310724
    [No Abstract] [Full Text] [Related]

  • 22. Poliomyelitis in a high risk population: do we need to immunize the newborn?
    Miller LW, McGowan JE, Leffingwell LM.
    Pediatrics; 1972 Apr; 49(4):532-5. PubMed ID: 5013416
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?].
    Fescharek R, Arras-Reiter C, Arens ER, Quast U, Maass G.
    Wien Med Wochenschr; 1997 Apr; 147(19-20):456-61. PubMed ID: 9471843
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Occurrence, role and characteristics of human Enteroviruses in Poland 1973-1982. II. Polioviruses].
    Jarzabek Z.
    Med Dosw Mikrobiol; 1985 Apr; 37(3-4):179-95. PubMed ID: 3007895
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. From the Centers for Disease Control and Prevention. Paralytic poliomyelitis--United States, 1980-1994.
    JAMA; 1997 Feb 19; 277(7):525-6. PubMed ID: 9032147
    [No Abstract] [Full Text] [Related]

  • 31. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J.
    Dev Biol Stand; 1979 Feb 19; 43():151-7. PubMed ID: 230106
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Epidemiology and control of poliomyelitis. II. Poliovirus vaccines].
    Carrada-Bravo T.
    Bol Med Hosp Infant Mex; 1983 Nov 19; 40(11):604-12. PubMed ID: 6651947
    [No Abstract] [Full Text] [Related]

  • 34. Control of paralytic poliomyelitis in the United States.
    Schonberger LB, Kaplan J, Kim-Farley R, Moore M, Eddins DL, Hatch M.
    Rev Infect Dis; 1984 Nov 19; 6 Suppl 2():S424-6. PubMed ID: 6740085
    [Abstract] [Full Text] [Related]

  • 35. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
    Samoilovich EO, Feldman EV, Yermalovich MA, Protas II, Titov LP.
    Cent Eur J Public Health; 2003 Dec 19; 11(4):213-8. PubMed ID: 14768785
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Paralytic poliomyelitis: clinical and virological studies.
    Ratnaswamy L, John TJ, Jadhav M.
    Indian Pediatr; 1973 Jul 19; 10(7):443-7. PubMed ID: 4357456
    [No Abstract] [Full Text] [Related]

  • 40. Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after.
    Lasch EE, Abed Y, Marcus O, Gerichter CB, Melnick JL.
    Dev Biol Stand; 1986 Jul 19; 65():137-43. PubMed ID: 3556771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.